Trial Parameters
Brief Summary
With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients treated with combination antiretroviral therapy will provide further insights into the long-term safety and durability of various antiretroviral therapeutic approached, the efficacy of HIV viral load and CD4 cell counts as predictors of disease progression and mortality, and the importance of adherence.
Eligibility Criteria
Inclusion Criteria: * HIV infected patients( children and adults) previously participated HIV-NAT studies * HIV infected patients( children and adults) currently participate in HIV-NAT trials * Able to provide written consent Exclusion Criteria: * Unable to provide written consent